@article {647,
	title = {Interaction of trivalent axsenicals with metallothionein},
	journal = {Chemical Research in Toxicology},
	volume = {16},
	number = {7},
	year = {2003},
	note = {ISI Document Delivery No.: 702UQTimes Cited: 53Cited Reference Count: 625th International Conference on Arsenic Exposure and Health EffectsJUL 14-18, 2002SAN DIEGO, CALIFORNIA},
	month = {Jul},
	pages = {873-880},
	type = {Proceedings Paper},
	abstract = {Arsenic is a human carcinogen, causing skin, bladder, and lung cancers. Although arsenic in drinking water affects millions of people worldwide, the mechanism(s) of action by which arsenic causes cancers is not known. Arsenic probably exerts some toxic effects by binding with proteins. However, few experimental data are available on arsenic-containing proteins in biological systems. This study reports on arsenic interaction with metallothionein and established binding stoichiometries between metallothionein and the recently discovered trivalent metabolites of arsenic metabolism. Size exclusion chromatography with inductively coupled plasma mass spectrometry analysis of reaction mixtures between trivalent arsenicals and metallothionein clearly demonstrated the formation of complexes of arsenic with metallothionein. Analysis of the complexes using electrospray quadrupole time-of-flight tandem mass spectrometry revealed the detailed binding stoichiometry between arsenic and the 20 Cys residues in the metallothionein molecule. Inorganic arsenite (As-III) and its two trivalent methylation metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), readily bind with metallothionein. Each metallothionein molecule could bind with up to six As-III, 10 MMA(III), and 20 DMA(III) molecules, consistent with the coordination chemistry of these arsenicals. The findings on arsenic interaction with proteins are useful for a better understanding of arsenic health effects.},
	keywords = {ARSENIC METABOLITES, ENZYMATIC METHYLATION, GLUTATHIONE-REDUCTASE, HUMAN URINE, INORGANIC ARSENICALS, MONOMETHYLARSONOUS ACID MMA(III), PYRUVATE-DEHYDROGENASE, RABBIT LIVER, THIOREDOXIN REDUCTASE, TOXICITY},
	isbn = {0893-228X},
	url = {<Go to ISI>://000184243200009},
	author = {Jiang, G. F. and Gong, Z. L. and Li, X. F. and Cullen, W. R. and Le, X. C.}
}
@article {386,
	title = {Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate},
	journal = {Chemical Research in Toxicology},
	volume = {15},
	number = {10},
	year = {2002},
	note = {ISI Document Delivery No.: 607TXTimes Cited: 15Cited Reference Count: 42},
	month = {Oct},
	pages = {1318-1323},
	type = {Article},
	abstract = {Sodium 2,3-dimercapto-1-propane sulfonate (DMPS) has been used to treat acute arsenic poisoning. Presumably DMPS functions by chelating some arsenic species to increase the excretion of arsenic from the body. However, the excreted complex of DMPS with arsenic has not been detected. Here we describe a DMPS complex with monomethylarsonous acid (MMA(III)), a key trivalent arsenic in the arsenic methylation process, and show the presence of the DMPS-MMA(III) complex in human urine after the administration of DMPS. The DMPS-MMA(III) complex was characterized using electrospray tandem mass spectrometry and determined by using HPLC separation with hydride generation atomic fluorescence detection (HGAFD). The DMPS-MMAIII complex did not form a volatile hydride with borohydride treatment. On-line digestion with 0.1 M sodium hydroxide following HPLC separation decomposed the DMPS-MMA(III) complex and allowed for the subsequent quantification by hydride generation atomic fluorescence. Arsenite (As-III), arsenate (As-V), monomethylarsonic, acid (MMA(V)), dimethylarsinic acid (DMA(V)), MMA(III), and DMPS-MMA(III) complex were analyzed in urine samples from human subjects collected after the ingestion of 300 mg of DMPS. The administration of DMPS resulted in a decrease of the DMA(V) concentration and an increase of the MMA(V) concentration excreted in the urine, confirming the previous results. The finding of the DMPS-MMA(III) complex in human urine after DMPS treatment provides an explanation for the inhibition of arsenic methylation by DMPS. Because MMA(III) is the substrate for the biomethylation of arsenic from MMA(V) to DMA(V), the formation of DMPS-MMA(III) complex would reduce the availability of MMA(III) for the subsequent biomethylation.},
	keywords = {ARSENICALS, CHALLENGE TEST, DRINKING-WATER, ENZYMATIC, GLUTATHIONE-REDUCTASE, HUMAN HEPATOCYTES, IN-VITRO INHIBITION, LIVER, METHYLATED, METHYLATION, MONOMETHYLARSONOUS ACID MMA(III), RABBIT, THIOREDOXIN REDUCTASE},
	isbn = {0893-228X},
	url = {<Go to ISI>://000178807800016},
	author = {Gong, Z. and Jiang, G. F. and Cullen, W. R. and Aposhian, H. V. and Le, X. C.}
}
@article {5144,
	title = {Methylated trivalent arsenic species are genotoxic},
	journal = {Chemical Research in Toxicology},
	volume = {14},
	number = {4},
	year = {2001},
	note = {ISI Document Delivery No.: 424XZTimes Cited: 253Cited Reference Count: 55},
	month = {Apr},
	pages = {355-361},
	type = {Article},
	abstract = {The reactivities of methyloxoarsine (MAsIII) and iododimethylarsine (DMAsIII), two methylated trivalent arsenicals, toward supercoiled phi X174 RFI DNA were assessed using a DNA nicking assay. The induction of DNA damage by these compounds in vitro in human peripheral lymphocytes was assessed using a single-cell gel (SCG, "comet") assay. Both methylated trivalent arsenicals were able to nick and/or completely degrade phi X174 DNA in vitro in 2 h incubations at 37 degreesC (pH 7.4) depending on concentration. MAsIII was effective at nicking phi X174 DNA at 30 mM; however, at 150 muM DMAsIII, nicking could be observed. Exposure of (phi X174 DNA to sodium arsenite (iAs(III); from 1 nM up to 300 mM), sodium arsenate (from 1 muM to 1 M), and the pentavalent arsenicals, monomethylarsonic acid (from 1 muM to 3 M) and dimethylarsinic acid (from 0.1 to 300 mM), did not nick or degrade phi X174 DNA under these conditions. In the SCG assay in human lymphocytes, methylated trivalent arsenicals were much more potent than any other arsenicals that were tested. On the basis of the slopes of the concentration-response curve for the tail moment in the SCG assay, MAsIII and DMAsIII were 77 and 386 times more potent than iAs(III), respectively. Because methylated trivalent arsenicals were the only arsenic compounds that were observed to damage naked DNA and required no exogenously added enzymatic or chemical activation systems, they are considered here to be direct-acting forms of arsenic that are genotoxic, though they are not, necessarily, the only genotoxic species of arsenic that could exist.},
	keywords = {CELLS, DIMETHYLARSINIC ACID, DRINKING-WATER, ENZYMATIC METHYLATION, FIBROBLASTS, GLUTATHIONE-REDUCTASE, HUMAN, HUMAN URINE, INHIBITION, MONOMETHYLARSONOUS ACID, SODIUM ARSENITE},
	isbn = {0893-228X},
	url = {<Go to ISI>://000168260400005},
	author = {Mass, M. J. and Tennant, A. and Roop, B. C. and Cullen, W. R. and Styblo, M. and Thomas, D. J. and Kligerman, A. D.}
}
@article {5083,
	title = {Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid},
	journal = {Journal of Analytical Atomic Spectrometry},
	volume = {16},
	number = {12},
	year = {2001},
	note = {ISI Document Delivery No.: 498MYTimes Cited: 95Cited Reference Count: 52},
	pages = {1409-1413},
	type = {Article},
	abstract = {Two key arsenic metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), have recently been detected in human urine. There is an increasing interest in the speciation of these metabolites in humans because of their demonstrated effects on cellular toxicity and DNA damage. However, there is no information on the oxidative stability of these arsenic species. It is not known whether and to what extent these trivalent metabolites are changed during sample handling and storage. The objective of this study was to demonstrate the oxidative conversion of these arsenic species during sample storage. We compared the effects of the storage temperature (25, 4, and -20 degreesC) and storage duration (up to 5 months) on the stability of MMA(III) and DMA(III) in de-ionized water and in human urine. We used HPLC with hydride generation atomic fluorescence detection for the speciation of arsenic. This method provided sub-mug L-1 to low-mug L-1 detection limits for each arsenic species. We found that the oxidation of MMA(III) and DMA(III) was matrix and temperature dependent. Low temperature conditions (4 and -20 degreesC) improved the stability of these arsenic species over the room temperature storage condition. MMA(III) in de-ionized water was relatively stable for almost 4 months, when stored at 4 or -20 degreesC with less than 10\% of MMA(III) oxidized to MMA(V). In contrast, most of MMA(III) ( 90\%) in urine was oxidized to MMA(V) over the 5 month period under the 4 or -20 degreesC storage condition. At 25 degreesC, MMA(III) in urine was completely oxidized to MMA(V) within a week. DMA(III) in deionized water was stable for only 2-3 days, being rapidly oxidized to DMA(V). DMA(III) in urine was completely oxidized to DMA(V) within a day at 4 or -20 degreesC. The conversion of DMA(III) to DMA(V) in urine at 25 degreesC was complete in 17 h. These results show that MMA(III) and DMA(III) are much less stable than other arsenic species, and their stability depends on sample matrix and temperature.},
	keywords = {ATOMIC FLUORESCENCE DETECTION, BLACKFOOT DISEASE, chemical, DRINKING-WATER, ENZYMATIC, GLUTATHIONE-REDUCTASE, HUMAN HEPATOCYTES, HUMAN URINE, LIQUID-CHROMATOGRAPHY, METHYLATION, RABBIT LIVER, SPECIATION},
	isbn = {0267-9477},
	url = {<Go to ISI>://000172516100011},
	author = {Gong, Z. L. and Lu, X. F. and Cullen, W. R. and Le, X. C.}
}
@article {4862,
	title = {Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine},
	journal = {Environmental Health Perspectives},
	volume = {108},
	number = {11},
	year = {2000},
	note = {ISI Document Delivery No.: 373XPTimes Cited: 101Cited Reference Count: 48},
	month = {Nov},
	pages = {1015-1018},
	type = {Article},
	abstract = {In this study we report on the finding of monomethylarsonous acid [MMA(III)I in human urine. This newly identified arsenic species is a key intermediate in the metabolic pathway of arsenic biomethylation, which involves stepwise reduction of pentavalent to trivalent arsenic species followed by oxidative addition of a methyl group. Arsenic speciation was carried out using ion-pair chromatographic separation of arsenic compounds with hydride generation atomic fluorescence spectrometry detection. Speciation of the inorganic arsenite [As(III)], inorganic arsenate [As(V)], monomethylarsonic acid [MMA(V)], dimethylarsinic acid [DMA(V)], and MMA(III) in a urine sample was complete in 5 min. Urine samples collected from humans before and after a single oral administration of 300 mg sodium 2,3-dimercapto-1-propane sulfonate (DMPS) were analyzed for arsenic species. MMA(III) was found in 51 out of 123 urine samples collected from 41 people in inner Mongolia 0-6 hr after the administration of DMPS. MMA(III)in urine samples did not arise from the reduction of MMA(V) by DMPS. DMPS probably assisted the release of MMA(III) that was formed in the body. Along with the presence of MMA(III), there was an increase in the relative concentration of MMA(V) and a decrease in DMA(V) in the urine samples collected after the DMPS ingestion.},
	keywords = {3-dimercapto-1-propane sulfonate, ARSENIC SPECIATION, BIOMARKERS, CARCINOGENESIS, CHEMICAL FORMS, DIMETHYLARSINIC ACID, ENZYMATIC METHYLATION, EXCRETION, EXPOSURE, GLUTATHIONE-REDUCTASE, INGESTION, METABOLISM, METABOLITES, METHYLATION, MONOMETHYLARSONOUS ACID, sodium 2, SPECIATION, trivalent methylarsenic species, urine metabolites},
	isbn = {0091-6765},
	url = {<Go to ISI>://000165315600019},
	author = {Le, X. C. and Ma, M. S. and Lu, X. F. and Cullen, W. R. and Aposhian, H. V. and Zheng, B. S.}
}
@article {4600,
	title = {Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase},
	journal = {Chemical Research in Toxicology},
	volume = {12},
	number = {10},
	year = {1999},
	note = {ISI Document Delivery No.: 248DFTimes Cited: 114Cited Reference Count: 64},
	month = {Oct},
	pages = {924-930},
	type = {Article},
	abstract = {Thioredoxin reductase (TR, EC 1.6.4.5) was purified 5800-fold from the livers of adult male B6C3F1 mice. The estimated molecular mass of the purified protein was about 57 kDa, The activity of the purified enzyme was monitored by the NADPH-dependent reduction of 5,5{\textquoteright}-dithiobis(2-nitrobenzoic acid) (DTNB); this activity was fully inhibited by 1 mu M aurothioglucose. Arsenicals and arsinothiols, complexes of As-III-containing compounds with L-cysteine or glutathione, were tested as inhibitors of the DTNB reductase activity of the purified enzyme. Pentavalent arsenicals were much less potent inhibitors than trivalent arsenicals. Among all the arsenicals, CH3AsIII was the most potent inhibitor of TR. CH3AsIII was found to be a competitive inhibitor of the reduction of DTNB (K-i similar to 100 nM) and a noncompetitive inhibitor of the oxidation of NADPH. The inhibition of TR by CH3AsIII was time-dependent and could not be reversed by the addition of a dithiol-containing molecule, 2,3-dimercaptosuccinic acid, to the reaction mixture. The inhibition of TR by CH3AsIII required the simultaneous presence of NADPH in the reaction mixture. However, unlike other pyridine nucleotide disulfide oxidoreductases, there was no evidence that mouse liver TR was inactivated by exposure to NADPH. Treatment with CH3AsIII did not increase the NADPH oxidase activity of the purified enzyme. Thus, CH3AsIII, a putative intermediate in the pathway for the biomethylation of As, is a potent and irreversible inhibitor of an enzyme involved in the response of the cell to oxidative stress.},
	keywords = {ARSENATE REDUCTASE, CANCER-CELLS, ENDOTHELIAL-CELLS, ESCHERICHIA-COLI, GLUTATHIONE-REDUCTASE, KAPPA-B ACTIVATION, LIPOAMIDE DEHYDROGENASE, MAMMALIAN THIOREDOXIN, MULTI-ENZYME COMPLEX, RABBIT ERYTHROCYTES},
	isbn = {0893-228X},
	url = {<Go to ISI>://000083259500008},
	author = {Lin, S. and Cullen, W. R. and Thomas, D. J.}
}
